Adults 18 to 84, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Fugl-Meyer Arm Motor Assessment Score (FMAMA)Primary· Baseline upon admission (assessed within 3 days upon admission), Post-intervention evaluation at discharge (At discharge: assessed up to 3 weeks post baseline), and 3-month post-stroke evaluation (Follow up occurred at Month 3 after Baseline)
The investigators measure the change of the Fugl-Meyer Arm Motor Assessment scores from the baseline evaluation to the 3-month post stroke follow up evaluation. Fugl-Meyer Arm Motor Assessment is a 66-point scale measuring the movement pattern of the upper extremities. The minimum score is zero and the maximum score is 66. The higher scores indicate a better outcome.
Change in score (PI - BL)
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
11.8
± 6.8
Electronic Arm Exercises
6.9
± 6.9
Change in score (FU - BL)
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
18.6
± 11.3
Electronic Arm Exercises
19.2
± 9.4
Modified Ashworth Spasticity Scale (MASS)Secondary· Baseline upon admission (assessed within 3 days upon admission), Post-intervention evaluation at discharge (At discharge: assessed up to 3 weeks post baseline), and 3-month post-stroke evaluation (Follow up occurred at Month 3 after Baseline)
The investigators measure the spasticity of the upper extremity at baseline, post-intervention, and at the 3-month post stroke follow up evaluation. Spasticity is described as the resistance to passive movement. Participants are asked to relax and evaluators assess muscle resistance to passive movement at one joint at a time: Shoulder, elbow, wrist, and fingers. The evaluator will then grade the resistance on a 6-point scale for each joint. Higher scores indicate more rigid movement or more muscle tone resistance. The minimum score is zero and the maximum score is 4.
MASS of elbow at BL
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
1.7
± 1.1
Electronic Arm Exercises
1.7
± 1.1
MASS of elbow at PI
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
1.7
± 1.3
Electronic Arm Exercises
1.5
± 1.1
MASS of elbow at FU
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
1.9
± 1.5
Electronic Arm Exercises
1.9
± 1.1
MASS of wrist at BL
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
0.9
± 0.9
Electronic Arm Exercises
1.0
± 1.1
MASS of wrist at PI
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
1.3
± 1.1
Electronic Arm Exercises
1.0
± 0.8
MASs of wrist at FU
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
1.5
± 1.1
Electronic Arm Exercises
1.4
± 1.0
Box and Blocks TestSecondary· Baseline upon admission (assessed within 3 days upon admission), Post-intervention evaluation at discharge (At discharge: assessed up to 3 weeks post baseline), and 3-month post-stroke evaluation (Follow up occurred at Month 3 after Baseline)
The investigators measure the Box and Blocks Test scores at baseline, post-intervention, and at 3-month post stroke follow up evaluation. Participants are instructed to move as many blocks as possible, one at a time, from one compartment in a box to a second compartment over a divider for a period of 60 seconds; each block that is moved is counted, and multiple blocks moved at the same time are counted as a single block. The higher scores indicate a better outcome.
BBT at BL
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
3.2
± 5.9
Electronic Arm Exercises
1.9
± 4.7
BBT at PI
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
8.2
± 9.4
Electronic Arm Exercises
6.7
± 9.6
BBT at FU
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
16.0
± 14.3
Electronic Arm Exercises
22.5
± 14.9
Shoulder Subluxation DistanceSecondary· Baseline upon admission (assessed within 3 days upon admission), Post-intervention evaluation at discharge (At discharge: assessed up to 3 weeks post baseline), and 3-month post-stroke evaluation (Follow up occurred at Month 3 after Baseline)
The investigators measure the shoulder subluxation distance at baseline, post-intervention, and at 3-month post stroke follow up evaluation. Participants are asked to be seated in a upright chair and relax their affected upper extremity. The evaluator measures the distance, in centimeter, between the inferior aspect of the acromion and the superior aspect of the humeral head. The lower scores indicate a better outcome.
Shoulder subluxation distance at BL
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
0.6
± 0.7
Electronic Arm Exercises
0.6
± 0.9
Shoulder subluxation distance at PT
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
0.4
± 0.8
Electronic Arm Exercises
0.2
± 0.4
Shoulder subluxation distance at FU
Group
Value
95% CI
Boost - Moveable Wheelchair Arm Rest
0.5
± 0.8
Electronic Arm Exercises
0.3
± 0.6
Sponsor's own description
The purpose of this research study is to measure the effect of participating in extra arm exercise in addition to standard rehabilitation exercises in the Acute Rehabilitation Unit. This study will compare two different ways to perform the extra arm exercise. The first is following a customized program of hand and arm exercises that will be developed for study participants by an experienced rehabilitation therapist. The second is moving a participants arm back and forth when they are sitting in their wheelchair by using a moveable wheelchair arm rest (Boost).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
· recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment
· NA
· recruiting
NCT07356011 — Exoskeleton for Balance
· NA
· recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in
· NA
· recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients
· NA
· recruiting
Other University of California, Irvine trials
Trials by the same sponsor.
NCT06952725 — Chatbot for Online Support Groups to Treat Tobacco Addiction
· NA
· not yet recruiting
NCT07167862 — Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound
· Phase 4
· not yet recruiting
NCT07527325 — Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma
· Phase 2
· not yet recruiting
NCT07391891 — Musical Mindfulness for Pain in the ED Waiting Room
· NA
· not yet recruiting
NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Irvine
Last refreshed: 27 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05880940.